Radiation therapy after surgery to remove breast cancer improves control of the breast cancer. Standard therapy after breast conservation surgery is five to six weeks of radiation to the entire breast. This clinical trial will evaluate the effectiveness of conformal radiation therapy delivered only to the area in the breast where the lumpectomy will be performed. This study will determine if radiation therapy delivered in this manner will prevent the cancer from coming back and eliminate the need for five to six weeks of radiation. Eligible participants will be randomized to one of two arms; Arm 1 which is comprised of one neoadjuvant radiation treatment, or Arm 2 which is comprised of three neoadjuvant radiation treatments. The study will also gather information about the safety and effects (good and bad) this radiation has, the immune priming effects of this radiation, and on patient satisfaction with the appearance of the breast.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Immune priming will be measured
Timeframe: 1.5 years
Angiogenesis will be measured
Timeframe: 1.5 years
Proliferation markers will be measured
Timeframe: 1.5 years
Hypoxia markers will be measured
Timeframe: 1.5 years
Apoptosis markers will be measured
Timeframe: 1.5 years
Invasion markers will be measured
Timeframe: 1.5 years
Toxicity resulting from radiation treatment
Timeframe: 1.5 years